SCHEMBL584704

SCHEMBL584704

NC1=NOc2ccccc2C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
NOS3 P29474 2/20 0.35
NOS2 P35228 2/20 0.35
NOS1 P29475 1/20 0.35
MAPKAPK2 P49137 1/20 0.34
LMNA P02545 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 3/20 0.32
ALDH1A1 P00352 3/20 0.32
GAA P10253 2/20 0.32
MAPT P10636 2/20 0.32
TSHR P16473 1/20 0.31
OXTR P30559 1/20 0.31
ABCG2 Q9UNQ0 1/20 0.31
ITGB2 P05107 1/20 0.31
ICAM1 P05362 1/20 0.31
ITGAL P20701 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1871104 0.79 MAOA (0.46) MAOAMAOBMAPKAPK2LMNANPC1
SCHEMBL3074959 0.78 MAOA (0.50) MAOAMAOBLMNANPC1RAB9A
SCHEMBL574574 0.77 MAOA (0.48) MAOAMAOBGAAOXTRABCG2
SCHEMBL1493436 0.76 MAOA (0.39) MAOAMAOBNOS3NOS2NOS1
SCHEMBL2075820 0.75 MAOA (0.46) MAOAMAOBOXTRABCG2ITGB2
SCHEMBL1491183 0.75 MAOA (0.46) MAOAMAOBRAB9AALDH1A1MAPT
SCHEMBL3235013 0.75 MAOA (0.46) MAOAMAOBOXTRABCG2ITGB2
SCHEMBL15284925 0.75 MAOA (0.46) MAOAMAOBOXTRABCG2ITGB2
SCHEMBL5181287 0.75 MAOA (0.46) MAOAMAOBLMNASMN1; SMN2KDM4E
SCHEMBL2596861 0.75 MAOA (0.46) MAOAMAOBOXTRABCG2ITGB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122059968-A Halogen-free and phosphorus-free intrinsic flame-retardant trifunctional benzoxazine monomer, nitrogen-rich resin, preparation method and application thereof 淮北绿洲新材料有限责任公司 2026-05-19 CN claimed
CN-122036758-A Halogen-free and phosphorus-free intrinsic flame-retardant tetrafunctional benzoxazine monomer, nitrogen-rich resin, preparation method and application thereof 淮北绿洲新材料有限责任公司 2026-05-15 CN claimed
CN-120082078-A Masking protection film for automobile paint spraying and preparation method thereof 青岛奥盛塑胶有限公司 2025-06-03 CN claimed
CN-119242286-A High-temperature-resistant foaming agent and preparation method thereof 滨州乾坤化工机械有限公司 2025-01-03 CN claimed
CN-118599406-A Anti-slip coating and preparation method thereof 廊坊赛尔孚环保科技有限公司 2024-09-06 CN claimed
CN-118272004-B Polyethylene adhesive and preparation method thereof 广饶齐成新能源有限公司 2024-07-26 CN claimed
CN-118272004-A Polyethylene adhesive and preparation method thereof 广饶齐成新能源有限公司 2024-07-02 CN claimed
CN-118109945-A High-strength flame-retardant elastic fabric and preparation method thereof 合肥楚欣纺织有限公司 2024-05-31 CN claimed
CN-118088793-A High-strength steel wire mesh composite polyethylene pipe and preparation method thereof 河南青龙塑料管业有限公司 2024-05-28 CN claimed
CN-112673043-B Curing agent composition for epoxy resin mixtures, epoxy resin mixtures and multicomponent epoxy resin systems 喜利得股份公司 2024-03-29 CN claimed
US-20020194685-A1 Composition for dyeing keratin fibres, comprising a pyrazoline-4, 5-dione and an aromatic primary amine L'OREAL S.A. (FR) 2002-12-26 US claimed
US-6464732-B2 HAIR DYE MIXTURE L'OREAL S.A. (FR) 2002-10-15 US claimed
WO-2001016139-A9 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARM INC (US) 2002-09-19 WO claimed
EP-1212330-A1 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 2002-06-12 EP claimed
US-20020040508-A1 COMPOSITION FOR DYEING KERATIN FIBRES,COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE L'OREAL S.A. (FR) 2002-04-11 US claimed
WO-2001016139-A1 ANDROGEN RECEPTOR MODULATOR COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS INCORPORATED (US) 2001-03-08 WO claimed
EP-0981320-A1 COMPOSITION FOR DYEING KERATIN FIBRES COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE L'OREAL (FR) 2000-03-01 EP claimed
WO-1998051268-A1 COMPOSITION FOR DYEING KERATIN FIBRES COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE L'OREAL (FR) 1998-11-19 WO claimed
CN-1051910-A Benzoxazine derivatives and pharmaceutical compositions containing them YAMANOUCHI PHARMRCEUTICAL (JP) 1991-06-05 CN claimed
EP-0103797-B1 SUBSTITUTED BENZOXAZINE DERIVATIVES BAYER AG (DE) 1986-11-26 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020194685-A1 Composition for dyeing keratin fibres, comprising a pyrazoline-4, 5-dione and an aromatic primary amine KRT18, KLK5, MARK1 MAOA 439/4885MAOB 716/4885NOS3 1428/4885
US-20020040508-A1 COMPOSITION FOR DYEING KERATIN FIBRES,COMPRISING A PYRAZOLIN-4,5-DIONE AND AN AROMATIC PRIMARY AMINE KRT18, KLK5, H1-5 MAOA 412/4885MAOB 601/4885NOS3 1498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.